About

Log in?

DTU users get better search results including licensed content and discounts on order fees.

Anyone can log in and get personalized features such as favorites, tags and feeds.

Log in as DTU user Log in as non-DTU user No thanks

DTU Findit

Journal article

An in vitro methodology for discovering broadly-neutralizing monoclonal antibodies

From

Department of Biotechnology and Biomedicine, Technical University of Denmark1

Disease Systems Immunology, Section for Protein Science and Biotherapeutics, Department of Biotechnology and Biomedicine, Technical University of Denmark2

Tropical Pharmacology and Biotherapeutics, Section for Protein Science and Biotherapeutics, Department of Biotechnology and Biomedicine, Technical University of Denmark3

Technical University of Denmark4

DTU Proteomics Core, Section for Protein Science and Biotherapeutics, Department of Biotechnology and Biomedicine, Technical University of Denmark5

Eşkisehir Osmangazi University6

Broadly-neutralizing monoclonal antibodies are of high therapeutic utility against infectious diseases caused by bacteria and viruses, as well as different types of intoxications. Snakebite envenoming is one such debilitating pathology, which is currently treated with polyclonal antibodies derived from immunized animals.

For the development of novel envenoming therapies based on monoclonal antibodies with improved therapeutic benefits, new discovery approaches for broadly-neutralizing antibodies are needed. Here, we present a methodology based on phage display technology and a cross-panning strategy that enables the selection of cross-reactive monoclonal antibodies that can broadly neutralize toxins from different snake species.

This simple in vitro methodology is immediately useful for the development of broadly-neutralizing (polyvalent) recombinant antivenoms with broad species coverage, but may also find application in the development of broadly-neutralizing antibodies against bacterial, viral, and parasitic agents that are known for evading therapy via resistance mechanisms and antigen variation.

Language: English
Publisher: Nature Publishing Group UK
Year: 2020
Pages: 10765
ISSN: 20452322
Types: Journal article
DOI: 10.1038/s41598-020-67654-7
ORCIDs: Ahmadi, Shirin , Jürgensen, Jonas A. , Ledsgaard, Line , Schoof, Erwin M. , Sørensen, Christoffer V. and Laustsen, Andreas H.

DTU users get better search results including licensed content and discounts on order fees.

Log in as DTU user

Access

Analysis